Finance

Beta
Lists
524717:BOM
Titan Biotech Ltd
₹447.75
+1.24%
(+5.50) 1D
Jun 5, 2:23:14 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524717...
Open
₹434.00
High
₹458.00
Low
₹425.10
Mkt. cap
18.50B
Avg. vol.
39.80K
Volume
33.94K
Dividend
0.09%
Quarterly dividend
₹0.10
Ex-dividend date
Sep 19, 2025
P/E ratio
61.93
52-wk high
₹555.65
52-wk low
₹74.73
EPS
₹7.23
Shares outstanding
7.74M
No. of employees
467
Open
₹434.00
High
₹458.00
Low
₹425.10
Mkt. cap
18.50B
Avg. vol.
39.80K
Volume
33.94K
Dividend
0.09%
Quarterly dividend
₹0.10
Ex-dividend date
Sep 19, 2025
P/E ratio
61.93
52-wk high
₹555.65
52-wk low
₹74.73
EPS
₹7.23
Shares outstanding
7.74M
No. of employees
467
News stories
From sources across the web
About Titan Biotech Ltd
CEO-
Employees467
Founded1992
Headquarters-
SectorSpeciality chemicals
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
464.96M
543.55M
565.06M
509.40M
Cost of goods sold
239.50M
260.49M
273.68M
188.29M
Cost of revenue
239.50M
260.49M
273.68M
188.29M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
70.13M
73.83M
85.31M
94.35M
Operating expense
149.62M
201.88M
195.76M
215.92M
Total operating expenses
389.11M
462.36M
469.43M
404.21M
Operating income
75.85M
81.18M
95.62M
105.19M
Other non operating income
7.22M
13.24M
12.57M
-
EBT including unusual items
88.14M
101.21M
112.22M
104.55M
EBT excluding unusual items
88.14M
101.21M
112.22M
104.55M
Income tax expense
19.51M
23.56M
26.94M
37.26M
Effective tax rate
22.14%
23.28%
24.00%
35.64%
Other operating expenses
67.97M
115.96M
97.78M
108.59M
Net income
68.63M
77.65M
85.29M
67.29M
Net profit margin
14.76%
14.29%
15.09%
13.21%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-1.95M
-2.24M
-2.57M
-2.37M
Net interest expenses
-1.95M
-2.24M
-2.57M
-2.37M
Depreciation and amortization charges
11.52M
12.10M
12.66M
12.98M
EBITDA
86.28M
92.99M
104.85M
117.50M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more